Lead Sponsor

University of British Columbia

Collaborators

Age

19 - 70 years

Sex

ALL

Healthy Volunteers

No

•primary diagnosis of PTSD as determined by a structured interview using the Mini International Neuropsychiatric Interview (MINI)
•no change in psychotropic medications within 4 weeks before the start of rTMS
•age \> 19 years and \< 70 years
•competency to give informed consent

•any non-fixed metal object or implant (including cochlear implants) in brain, skull, scalp, or neck within 30 cm of the magnetic rTMS coil
•implantable devices, including cardiac pacemakers and defibrillators
•other contraindications to rTMS, including history of seizures (except childhood febrile seizures) or recent and unexplained syncope, first-degree relative with a history of epilepsy, treatment with a medication known to substantially decrease the seizure threshold, or pregnancy
•psychiatric diagnoses of psychosis or psychotic disorder (including psychotic depression), bipolar type I disorder, or organic mental disorders
•substance abuse/dependence within the past 3 months
•active suicidal risk as judged by the clinician
•borderline or antisocial personality disorder
•acute medical illness, including cancer
•any significant central nervous system disorder, such as brain mass, stroke, etc.

Related studies

NCT07447089 · Thyroid Neoplasms, Neoplasm, and more

NCT06975280 · Post-Traumatic Stress Disorder (PTSD), Depressive Symptoms, and more

NCT07490717 · Post-traumatic Stress Disorder (PTSD), Post-traumatic Stress Symptoms, and more

NCT07290127 · Post-traumatic Stress Disorder (PTSD), Postpartum Mental Health

NCT07418554 · Post-traumatic Stress Disorder (PTSD), Current Significant Sleep Disturbances

rTMS in the Treatment of PTSD